Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.

Francis CW, Berkowitz SD, Comp PC, Lieberman JR, Ginsberg JS, Paiement G, Peters GR, Roth AW, McElhattan J, Colwell CW Jr; EXULT A Study Group..

N Engl J Med. 2003 Oct 30;349(18):1703-12.

2.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
3.
4.
5.
6.

A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era...

Mohapatra R, Tran M, Gore JM, Spencer FA.

Am Heart J. 2005 Jul;150(1):19-26. Review.

PMID:
16084146
7.

Ximelagatran: an orally active direct thrombin inhibitor.

Gulseth MP.

Am J Health Syst Pharm. 2005 Jul 15;62(14):1451-67. Review.

PMID:
15998925
8.

Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.

Koscielny J, Kiesewetter H, Jörg I, Harenberg J.

Clin Appl Thromb Hemost. 2007 Jul;13(3):299-307. Review.

PMID:
17636192
9.

Ximelagatran: direct thrombin inhibitor.

Ho SJ, Brighton TA.

Vasc Health Risk Manag. 2006;2(1):49-58. Review.

10.

Lessons from ximelagatran: issues for future studies evaluating new oral direct thrombin inhibitors for venous thromboembolism prophylaxis in orthopedic surgery.

Lazo-Langner A, Rodger MA, Wells PS.

Clin Appl Thromb Hemost. 2009 May-Jun;15(3):316-26. doi: 10.1177/1076029608326166. Review.

PMID:
19028773
11.

Ximelagatran--a promising new drug in thromboembolic disorders.

Petersen P.

Curr Pharm Des. 2005;11(4):527-38. Review.

PMID:
15725069
12.
13.

Stroke prevention in atrial fibrillation: pooled analysis of SPORTIF III and V trials.

Albers GW; SPORTIF Investigators..

Am J Manag Care. 2004 Dec;10(14 Suppl):S462-9; discussion S469-73. Review.

14.

Ximelagatran.

Choudhury A, Goyal D, Lip GY.

Drugs Today (Barc). 2006 Jan;42(1):3-19. Review.

PMID:
16511607
16.

Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.

Halperin JL.

Expert Rev Cardiovasc Ther. 2004 Mar;2(2):163-74. Review.

PMID:
15151465
17.
18.

[Ximelagatran for treatment of venous thromboembolism].

Harenberg J, Fenyvesi T, Jörg I.

Hamostaseologie. 2002 Aug;22(3):25-9. Review. German.

PMID:
12215758
19.

Ximelagatran in orthopaedic surgery.

Eriksson B.

Pathophysiol Haemost Thromb. 2005;34 Suppl 1:10-7. Review.

PMID:
15812199
20.

[Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].

Selçuk H, Selçuk MT, Maden O.

Anadolu Kardiyol Derg. 2007 Mar;7(1):54-8. Review. Turkish.

Supplemental Content

Support Center